Limited Clinical and Diagnostic Utility of Circulating Tumor DNA Detection in Patients with Early-Stage Well-Differentiated Thyroid Cancer: Comparison with Benign Thyroid Nodules and Healthy Individuals

Limited data are available on the diagnostic utility of circulating tumor DNA (ctDNA) in early-stage thyroid cancers for BRAF, KRAS, NRAS, and TERT promoter mutations, which are known detectable markers for thyroid cancers. Here, we analyzed the above driver mutations in ctDNA and matched neoplastic...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Yong Joon, Kwon, Mi Jung, Noh, Hye-Mi, Lee, Hong Kyu, Ra, Yong Joon, Kim, Nan Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065614/
https://www.ncbi.nlm.nih.gov/pubmed/33915745
http://dx.doi.org/10.3390/healthcare9040386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065614/
https://www.ncbi.nlm.nih.gov/pubmed/33915745
http://dx.doi.org/10.3390/healthcare9040386

Ejemplares similares